Human CXCR5 Antibody, R&D Systems™

CXCR5

Monoclonal

LYOPH

Flow Cytometry 0.25 ug/10^6 cells, Immunohistochemistry 8-25 ug/mL, Neutralization 0.25-1.5 ug/mL, Immunocytochemistry 8-25 ug/mL, CyTOF-reported

P32302

CXCR5

NS0 mouse myeloma cell line transfected with human CXCR5 Met1-Phe372 Accession # P32302

25 μg

Primary

Stains human CXCR5 transfectants but not the parental cell lines in flow cytometry. Does not cross-react with human CXCR2, CXCR3, or CXCR4 transfectants.

Human

Purified

Flow Cytometry, Immunohistochemistry, Neutralization, Immunocytochemistry, CyTOF

51505

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

BLR1, BLR1MDR-15, Burkitt lymphoma receptor 1, Burkitt lymphoma receptor 1, GTP binding protein (chemokine (C-X-C motif)receptor 5), Burkitt lymphoma receptor 1, GTP-binding protein, CD185, CD185 antigen, chemokine (C-X-C motif) receptor 5, C-X-C chemokine receptor type 5, CXCR5, CXC-R5, MDR15CXCR-5, MGC117347, Monocyte-derived receptor 15

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

643

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2b